A Prospective Randomized Multi-Center Comparison of the CYPHER Select Sirolimus-Eluting Stent and Balloon Re-Angioplasty for Treatment of Patients With Intra-Des Restenosis.

Trial Profile

A Prospective Randomized Multi-Center Comparison of the CYPHER Select Sirolimus-Eluting Stent and Balloon Re-Angioplasty for Treatment of Patients With Intra-Des Restenosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2010

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms CRISTAL
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 21 Sep 2010 Primary endpoint 'Late lumen loss' has not been met, according to results presented at the 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 21 Sep 2010 Results presented at the 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 28 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top